What changed
$RCL — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $4.5B | EPS $3.60 vs $3.20 🟢 | Margin 26.1%
💡 Consensus likely revised expectations upward after the beat, but the current multiple implies sustained peak profitability that is inconsistent with historical cyclicality. The market is wrong to price in little-to-no mean-reversion risk; a return to a 14.6x peer multiple would drop the stock to $292, a 9% decline.
📉 Reward/risk: 0.1:1
🏢 Business Quality: 7/10
📊 Valuation: rich — trading at 18.0x P/E vs peer band 8.0-14.6x and historical range 3.3-17.6x (103rd percentile).
🔮 Catalyst: Next earnings guidance update or macroeconomic data release
💰 Entry: $320.95, stop $350.0, target $292.29
⚖️ Avoid: high valuation, poor reward/risk, and negative quant signals suggest downside risk outweighs potential upside.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/RCL0625